• Publications
  • Influence
The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.
OBJECTIVE Despite a multitude of detection and treatment advances in the past 2 decades, prostate cancer remains the second leading cause of deaths due to cancer among men in the United States.Expand
  • 91
  • 3
Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder‐preservation therapy for muscle‐invasive bladder cancer
The current study was performed to examine temporal trends and compare overall survival (OS) in patients undergoing radical cystectomy (RC) or bladder‐preservation therapy (BPT) for muscle‐invasiveExpand
  • 44
  • 3
Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.
BACKGROUND Active surveillance (AS) has gained acceptance as a management strategy for localized renal masses. OBJECTIVE To review our large single-center experience with AS. DESIGN, SETTING, ANDExpand
  • 41
  • 2
Upper tract urothelial carcinoma: current treatment and outcomes.
The reference standard treatment of upper tract urothelial carcinoma is open radical nephroureterectomy. Many centers have advocated less-invasive treatment modalities. We reviewed contemporaryExpand
  • 41
  • 2
Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG‐ACRIN 2805) Adjuvant Trial
Purpose Lymphadenectomy is a well established practice for many urological malignancies but its role in renal cell carcinoma is less clear. Our primary objective was to determine whetherExpand
  • 25
  • 1
External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy
Purpose We sought to externally validate a mathematical formula for tumor contact surface area as a predictor of postoperative renal function in patients undergoing partial nephrectomy for renal cellExpand
  • 16
  • 1
Active Surveillance for the Small Renal Mass: Growth Kinetics and Oncologic Outcomes.
Active surveillance for small renal masses (SRMs) is an accepted management strategy for patients with prohibitive surgical risk. Emerging prospectively collected data support the concept that aExpand
  • 10
  • 1
The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer.
A lack of quality evidence comparing management strategies confounds complex treatment decisions for patients with high-risk prostate cancers. No randomized trial comparing surgery to radiation hasExpand
  • 9
  • 1
Angiosarcoma of the Adrenal Gland Treated Using a Multimodal Approach
Angiosarcoma of the adrenal gland is an extremely rare malignancy. We report a case of a 59-year-old female who presented with abdominal pain and profound anemia. A 7 cm enhancing, lipid-poor adrenalExpand
  • 5
  • 1
Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib‐II renal masses: An analysis of the national cancer data base
Partial nephrectomy (PN) is recommended for localized T1a (≤4 cm) renal masses and is preferred over radical nephrectomy (RN) for amenable T1b/T2 (>4 cm) tumors. The objective of the current studyExpand
  • 15